Charles River Labs Intl buy UBS Group AG
Start price
07.11.24
/
50%
€195.30
Target price
07.11.25
€231.75
Performance (%)
-25.40%
End price
08.11.25
€145.70
Summary
This prediction ended on 08.11.25 with a price of €145.70. The prediction for Charles River Labs Intl disappointed with a performance of -25.40%. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Charles River Labs Intl | 2.685% | 2.685% | -9.702% |
| iShares Core DAX® | 1.432% | 2.628% | 12.457% |
| iShares Nasdaq 100 | 1.892% | -0.458% | 1.248% |
| iShares Nikkei 225® | -1.619% | 11.097% | 27.382% |
| iShares S&P 500 | 1.921% | 1.159% | 1.635% |
Comments by UBS_Group_AG for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target raised by analysts at UBS Group AG from $240.00 to $250.00. They now have a "buy" rating on the stock.
Ratings data for CRL provided by MarketBeat
In the thread Trading Charles River Labs Intl
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten
Stopped prediction by UBS_Group_AG for Charles River Labs Intl
Charles River Labs Intl
Start price
Target price
Perf. (%)
€184.90
08.08.24
08.08.24
€220.15
08.08.25
08.08.25
-31.34%
09.08.25
09.08.25
Charles River Labs Intl
Start price
Target price
Perf. (%)
€227.80
15.02.24
15.02.24
€269.47
15.02.25
15.02.25
-36.02%
16.02.25
16.02.25
Charles River Labs Intl
Start price
Target price
Perf. (%)
€158.95
09.11.23
09.11.23
€201.48
09.11.24
09.11.24
26.14%
10.11.24
10.11.24